Breaking News, Promotions & Moves

Isis Names Akcea CEO

Soteropoulos will work to advance Isis' lipid franchise

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Isis Pharmaceuticals has appointed Paula Soteropoulos as president and chief executive officer of Akcea Therapeutics, Isis’ lipid franchise subsidiary responsible for the development and commercialization of ISIS-APOCIII, ISIS-APO(a), ISIS-ANGPTL3, and its more potent LICA follow-ons.   Ms. Soteropoulos will use her expertise to advance Isis’ novel lipid franchise through development and commercialization. She will also serve as a member of Isis’ leadership team.   Ms. Soteropoulos h...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters